Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 13,305

Document Document Title
WO/2014/206299A1
Disclosed in the present invention is a method for preparing a liflozin drug intermediate using a microreactor, comprising: mixing compound III dissolved in an organic solvent with an organometallic reagent in a microreactor unit (L) by ...  
WO/2014/146135A3
The present invention relates generally to steviol glycosides, as well as compositions comprising such steviol glycosides. The present invention further extends to methods of preparing and purifying such steviol glycosides and methods fo...  
WO/2014/203887A1
In the present invention, by applying a solution containing the fullerene represented by formula (1) to a substrate and firing at 450°C or higher, an n-type organic semiconductor thin film that has favorable ionization potential and has...  
WO/2014/204866A1
The present disclosure provides mixtures of prenylated flavonoids, stilbenes, or both with flavans or curcuminoids or both capable of modulating joint inflammation, joint pain, joint stiffness, cartilage degradation, or improving mobilit...  
WO/2014/115174A3
A process for synthesis of enatiomerically pure or enatiomerically enriched or racemic mixture of (+and/or-) epicatechin and its intermediates, comprising the steps of: (i) obtaining penta-protected quercetin; (ii) reducing the penta-pro...  
WO/2014/107652A3
The present invention provides vaccines comprising carbohydrate antigen conjugated to a diphtheria toxin (DT) as a carrier protein, wherein the ratio of the number of carbohydrate antigen molecule to the carrier protein molecule is highe...  
WO/2014/200363A1
The invention relates to sphingoglycolipid analogues which are useful in treating or preventing diseases and conditions such as those relating to infection, atopic disorders, autoimmune diseases or cancer.  
WO/2014/200964A1
The invention relates to processes for preparing (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside and compositions comprising the same.  
WO/2014/173957A3
A compound of formula (I) wherein R is a C9-23 polyunsaturated alkenyl group; X is SO3R3, SO2R3, PO3R3, PO2R3, COCHal3, or COOR3; R1 and R2 are each independently H, a C1-6 a iky I group optionally substituted with OH, C6-10 aryl group o...  
WO/2014/196887A1
Derived for the first time are individual (without the addition of penta- and hexa-acyl derivatives) di-, tri- and tetra-acyl S-LPS of endotoxic bacteria and combinations thereof, and the immunobiological, physicochemical and chemical...  
WO/2014/195828A1
The present invention relates to a novel method for synthesising, without a solvent, N-alkyl-glycosyl(di)amine derivatives represented by the following general formula (I): The invention also concerns the use of N-alkyl-glycosyl(di)amine...  
WO/2014/196861A1
A fructoside-containing product is manufactured from a glucose-rich feedstock, in a process wherein glucose to fructose is isomerized by contacting the glucose-rich feedstock with a basic isomerization catalyst in an alcoholic medium at ...  
WO/2014/193856A1
A method for the development of a library of modified sophorolipids using a wide- range of chemical and enzyme catalyst tools to identify modified sophorolipids that can be used in pure form, as mixtures with other modified sophorolipids...  
WO/2014/193183A1
The present invention relates to a method for preparing a sialic acid derivative, wherein the method is characterized in that a process of using N-acetyl-D-glucosamine to prepare CMP-M-acetylneuraminic acid and a process of combining sia...  
WO/2014/192848A1
 It was discovered that an arbekacin derivative containing arbekacin carbonate and a carbamate of arbekacin can be produced by adding carbon dioxide or the like to a solution containing arbekacin free base. It was also discovered that ...  
WO/2014/190024A1
The invention concerns compounds of the formula (I) wherein: Y1 and Y2 are independently a monosaccharide or disaccharide; X1 and X2 are independently -(R9-O)m-, -(R10)P-, -O-(R11-O)q-, -R16-O-R17-O- or a covalent bond; Q1 and Q2 are ind...  
WO/2014/190236A1
Embodiments in accordance with the present invention encompass water soluble poiyc-ycHc vinyl addition polymers having a norboraene type repeat unit derived from a norboraene type of monomer that encompasses a saccharide functional moiet...  
WO/2014/122407A3
A method for preparing a pyrazole of formula (I), characterised in that it involves reacting a sydnone of formula (II) with an alkyne of formula (III) in the presence of copper, in order to obtain a pyrazole compound of formula that is t...  
WO/2014/187365A1
The present invention relates to a oxabicyclo derivative, preparation method and use thereof, specifically to oxabicyclo derivatives shown by general formula (I) or hydrates, solvates, stereoisomers thereof, pharmaceutically acceptable s...  
WO/2014/187464A1
The present application discloses a synthetic mixture of oligosaccharides for treating a microbiota of a mammal, preferably a human, to reduce or eliminate the activity and/or the proportion of a microbe in the microbiota that is associa...  
WO/2014/183630A1
The present invention provides a compound as represented by formula I, which has a structure as follows: R1 and R2 are glycosyl, R3 is H, hydroxyl or methoxyl; R4 is hydroxyl or methoxyl; and R5 is H, hydroxyl or methoxyl. The present in...  
WO/2014/186027A1
Aryl or heteroaryl 1-substituted triazoles are prepared by cyclizing aryl or heteroaryl hydrazines with urea and alkyl orthoformates.  
WO/2014/178195A1
The present invention provides an immunity inducer and an immunity inducing method using same. The immunity inducer has an immunopotentiation effect on any target oligosaccharide antigen, in particular oligosaccharide antigens included i...  
WO/2014/140626A3
The present invention relates to a process for the preparation of polysaccharides of 8 or more monosaccharide residues in length and polysaccharides accessible by these processes, the process comprising coupling a chain extending polysac...  
WO/2014/145713A3
This disclosure relates generally to aminoglycoside derivatives of Formula (I) as described herein. The present disclosure also relates to pharmaceutical compositions containing these compounds and methods of treating bacterial infection...  
WO/2014/106826A3
The invention relates to purified compound of Formula 1. The invention includes all isomeric forms and tautomeric forms of the compound of Formula 1 and pharmaceutically acceptable salts and derivatives thereof. The present invention fur...  
WO/2014/173957A2
A compound of formula (I) wherein R is a C9-23 polyunsaturated alkenyl group; X is SO3R3, SO2R3, PO3R3, PO2R3, COCHal3, or COOR3; R1 and R2 are each independently H, a C1-6 a iky I group optionally substituted with OH, C6-10 aryl group o...  
WO/2014/167537A1
This invention relates to a chemo-enzymatic synthesis of oligosaccharidesof formula 1 wherein R is selected from -OH, -N3 and -OR6 wherein R6 is selected from allyl optionally substituted by one or more methyl, propargyl optionally subst...  
WO/2014/166139A1
The present invention relates to a method for synthesizing dibekacin and arbekacin. The method comprises: using kanamycin B as an initial raw material, protecting five amino groups of the kanamycin B by using t-butyloxycarboryl, protecti...  
WO/2014/165107A2
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I) The invention also provides processes for making the compounds described herein. Furthermore, the ...  
WO/2014/159211A1
An alkenyl glycoside is prepared by reacting a metathesis-derived unsaturated fatty alcohol containing 10 to 30 carbon atoms with either (1 ) a reducible monosaccharide or composition hydrolyzable to a reducible monosaccharide, or (2) a ...  
WO/2014/157635A1
The purpose of the present invention is to provide a drug that demonstrates a pharmaceutical effect by having high mobility to the mid-brain and converting to bumetanide in the mid-brain, which is the primary site of epilepsy. The presen...  
WO/2014/154958A1
Process for preparing a composition (C1) represented by the formula (I): HO-CH2-(CHOH)n-CH2-O-(G)x-H, in which G represents the remainder of a reducing sugar, n is an integer equal to 2, 3 or 4 and x, which indicates the mean degree of p...  
WO/2014/148718A1
The present invention provides a spirostenol derivative, a composition for inducing a bone formation and/or promoting an osteoblast differentiation which includes the spirostenol derivative as an active ingredient, a biomaterial for indu...  
WO/2014/146875A1
The current invention is directed towards compounds of the general formula (I), wherein the integers are defined as follows: R1 is -(CH2)nCH(CH3)2, R2 is -(CH2)n+2CH(CH3)2, G1 selected from monosaccharides with 4 to 6 carbon atoms, x in ...  
WO/2014/146135A2
The present invention relates generally to steviol glycosides, as well as compositions comprising such steviol glycosides. The present invention further extends to methods of preparing and purifying such steviol glycosides and methods fo...  
WO/2014/140626A2
The present invention relates to a process for the preparation of polysaccharides of 8 or more monosaccharide residues in length and polysaccharides accessible by these processes, the process comprising coupling a chain extending polysac...  
WO/2014/133268A1
Disclosed are a method for preparing coumestrol and a method for preparing coumestrin preparation, wherein chitosan is treated for a predetermined amount of time during a bean growth period. Additionally, disclosed is the method for prep...  
WO/2014/086775A3
The present invention relates to binder compositions with improved amine components, and a method of manufacturing a collection of matter bound by said binder compositions.  
WO/2014/128660A1
The invention relates to methods for making an α-amino-aldehyde, preferably a 2-amino-2-deoxy sugar derivative, from an α-hydroxy-aldehyde, preferably an aldose. Intermediary 1-amino-1-deoxy-ketose derivatives, and their use as synthet...  
WO/2014/124245A1
The invention is directed to compositions and methods related to proteins that are physically associated with ceramide-like glycolipids for use as activators of NKT cells. The compositions and methods of the present invention are useful ...  
WO/2014/070991A3
Provided herein are E-selectin antagonist therapeutic agents and improvements thereto and compositions comprising these E-selectin antagonists. Methods are also provided for using these E-selectin antagonist therapeutic agents to treat a...  
WO/2014/100158A1
The present invention relates to compounds useful for the treatment or prevention of bacteria infections. These compounds have formula (I). The invention also provides pharmaceutically acceptable compositions containing the compounds and...  
WO/2014/100700A1
Disclosed herein are cytoprotective derivatives of avicin D of formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising these derivative compounds. Meth...  
WO/2014/096331A1
The invention relates to a method for making an N-substituted D-mannosamine derivative of the following formula 1 and its salts wherein R1 is a non-electron-withdrawing group,and wherein R2 is -OH or R2 is –NHR3 wherein R3 is a group r...  
WO/2014/096377A1
New hydroxy aliphatic substituted phenyl aminoalkyi ether compounds of formula (I), compositions thereof and their use as a medicament in the treatment of nervous system diseases and/or the treatment of developmental, behavioral and/or m...  
WO/2014/098833A1
Polymorphic and amorphous forms of Rebaudioside X and methods for preparing the same are provided herein. Also provided herein are Rebaudioside X complexes and methods for preparing the same. Sweetener compositions and sweetened composit...  
WO/2014/089226A1
With the rise in resistance to antibiotics such as methicillin, there is a need for new drugs. The invention provides small molecules that inhibit cellular drug targets such as UPPS and FPPS by interacting with binding pockets, thereby p...  
WO/2014/088432A1
The invention relates to sphingoglycolipid analogues and peptide derivatives thereof, which are useful in treating or preventing diseases or such as those relating to infection, atopic disorders, autoimmune diseases or cancer.  
WO/2014/084744A1
The invention relates to dendritic compounds, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in w...  

Matches 501 - 550 out of 13,305